Abstract:Dependence of drug metabolism on dosing time has long been recognized. However, only recently are the underlying mechanisms for circadian drug metabolism being clarified. Diurnal rhythmicity in expression of drug-metabolizing enzymes is believed to be a key factor determining circadian metabolism. Supporting the notion that biological rhythms are generated and maintained by the circadian clock, a number of diurnal enzymes are under the control of the circadian clock. In general, circadian clock genes generate and regulate diurnal rhythmicity in drug-metabolizing enzymes via transcriptional actions on one or two of three cis-elements (i.e., E-box, D-box, and Rev-erb response element or RAR-related orphan receptor response element). Additionally, cycling or clock-controlled nuclear receptors such as hepatocyte nuclear factor 4α and peroxisome proliferator–activated receptor are contributors to diurnal enzyme expression. These newly discovered mechanisms for each of the rhythmic enzymes are reviewed in this article. We also discuss how the rhythms of enzymes are translated to circadian pharmacokinetics and drug chronotoxicity, which has direct implications for chronotherapeutics. Our discussion is also extended to two diurnal transporters (P-glycoprotein and multidrug resistance-associated protein 2) that have an important role in drug absorption. Although the experimental evidence is lacking in metabolism-based chronoefficacy, circadian genes (e.g., Rev-erbα) as drug targets are shown to account for diurnal variability in drug efficacy.SIGNIFICANCE STATEMENTSignificant progress has been made in understanding the molecular mechanisms for generation of diurnal rhythmicity in drug-metabolizing enzymes. In this article, we review the newly discovered mechanisms for each of the rhythmic enzymes and discuss how the rhythms of enzymes are translated to circadian pharmacokinetics and drug chronotoxicity, which has direct implications for chronotherapeutics.

The role of the circadian timing system on drug metabolism and detoxification: an update

Circadian Clock–Controlled Drug Metabolism: Implications for Chronotherapeutics

Understanding circadian dynamics: current progress and future directions for chronobiology in drug discovery

Role of the CLOCK protein in liver detoxification

Circadian rhythm in pharmacokinetics and its relevance to chronotherapy

Circadian timing of metabolism in animal models and humans

Circadian Clock Control of Liver Metabolic Functions

Implications of biological clocks in pharmacology and pharmacokinetics of antitumor drugs

Effect of Circadian Rhythm on Metabolic Processes and the Regulation of Energy Balance

Structure-based design and classifications of small molecules regulating the circadian rhythm period

Circadian Timing in Cancer Treatments

Circadian rhythms of liver physiology and disease: experimental and clinical evidence

Circadian Rhythms, Disease and Chronotherapy

Circadian Rhythms in Cardiovascular Metabolism

Circadian regulation of gene expression and metabolism in the liver.

Circadian Rhythms in Liver Physiology and Liver Diseases

Principles for circadian orchestration of metabolic pathways

Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models

Circadian rhythms and new options for novel anticancer therapies

Circadian rhythms and the molecular clock in cardiovascular biology and disease